BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  COVID-19 News: New Vaccines and Treatment Approaches Show Promise

  Companies continue to report promising data for vaccines and therapies against COVID-19. Here’s a look.

  May 26, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  BioMidwest

  Five VC Firms Repeatedly Flex Financial Muscles in Biopharma

  BioSpace looks at five of the top investor companies that support life sciences companies across the industry.

  May 26, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Money on the Move: May 19-25

  Drug development requires solid funding. Here’s who’s standing on higher ground this week with fresh investment dollars.

  May 26, 2021

   · 

  5 min read

   · 

  Kate Goodwin
• 

  Drug Development

  C4 Therapeutics Aims to Launch EGFR L858R Degrader Into the Clinic in 2022

  The company says it plans to file an IND for the candidate, dubbed CFT8919, by the middle of next year.

  May 26, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Vectura Group Undergoes $1.36 Billion Takeover by Global Investment Firm

  On Wednesday morning, the company announced that it would be undergoing a $1.36 billion takeover by global investment firm The Carlyle Group.

  May 26, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Drug Development

  Global Roundup: Abivax Eyes Phase III Following Positive UC Data

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  May 26, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  CytoReason and Ferring Pair Up, Using AI to Improve IBD Drug Options

  The purpose is to develop cell-based disease models to accelerate drug discovery and reduce development costs.

  May 26, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Emergent Enjoys Some Good News, Posting Positive Results for Chikungunya Vaccine

  Emergent said the vaccine candidate against the mosquito-borne illness showed an increase in immune response as measured by anti-chikungunya virus SNA.

  May 26, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  FDA Places Hold on Friedreich’s Ataxia Candidate After Nonhuman Primate Deaths

  This is after Larimar reported deaths in the highest dose levels of a nonhuman primate toxicology study.

  May 26, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  Engine and Giiant Scoop Up Fresh Funding for Cancer and IBD

  Engine is ready to drive its lead program into clinical trials by 2023 while Giiant’s preclinical program will target moderate-to-severe ulcerative colitis.

  May 26, 2021

   · 

  2 min read

   · 

  Kate Goodwin